{
    "nct_id": "NCT03163173",
    "official_title": "A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects",
    "inclusion_criteria": "1. Healthy, adult, male, 19-55 years of age, inclusive, at screening.\n2. Continuous non-smoker who has not used nicotine containing products for at least 3 months prior to dosing and throughout the study.\n3. Body mass index (BMI) ≥ 18.5 and ≤ 32.0 kg/m2 at screening.\n4. No clinically significant medical history, physical examination, laboratory profiles, vital signs or ECGs\n5. A non-vasectomized subject must agree to use a condom with spermicide or abstain from sexual intercourse during the study until 90 days beyond dosing.\n6. Must agree not to donate sperm from dosing until 90 days after dosing.\n7. Be willing and able to comply with the protocol.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 19 Years\nMust have maximum age of 55 Years",
    "exclusion_criteria": "1. Subject is mentally or legally incapacitated\n2. History or presence of clinically significant medical or psychiatric condition or disease\n3. History or presence of alcoholism or drug abuse within the past 2 years prior to dosing.\n4. History or presence of hypersensitivity or idiosyncratic reaction to the study drug or related compounds.\n5. Regularly has less than 1 bowel movement every 2 days.\n6. Recent history (within 2 weeks of Day 1) of abnormal bowel habits\n7. Positive results for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV).\n8. Blood pressure is less than 90/40 mmHg or greater than 140/90 mmHg\n9. Heart rate is lower than 40 bpm or higher than 99 bpm\n10. Unable to refrain from or anticipates the use of any drug, including prescription and non prescription medications, herbal remedies, or vitamin supplements beginning 14 days prior to dosing and throughout the study.\n11. Has been on a diet incompatible with the on study diet\n12. Donation of blood or significant blood loss within 56 days prior to dosing.\n13. Plasma donation within 7 days prior to dosing.\n14. Has received radiolabeled substances or has been exposed to radiation sources over the past 12 months or is likely to receive radiation exposure or radioisotopes within the next 12 months such that participation in this study would increase their total exposure beyond the recommended levels considered safe\n15. Participation in another clinical study within 28 days prior to dosing.",
    "miscellaneous_criteria": ""
}